Rectal absorption and mucosal irritation of rectal gels containing buprenorphine hydrochloride prepared with water-soluble dietary fibers, xanthan gum and locust bean gum

被引:9
作者
Watanabe, K
Yakou, S
Takayama, K
Isowa, K
Nagai, T
机构
[1] HOSHI UNIV,DEPT PHARMACEUT,SHINAGAWA KU,TOKYO 142,JAPAN
[2] CTR JAPAN BIOL CHEM CO LTD,GIFU 50306,JAPAN
关键词
buprenorphine; rectal absorption; dietary fiber; hydrogel; rectal irritation;
D O I
10.1016/0168-3659(95)00096-8
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Rectal gels prepared with water-soluble dietary fibers, xanthan gum and locust bean gum, were evaluated as a vehicle for the rectal administration of buprenorphine hydrochloride (BN-HCl) in rabbits. The maximum plasma concentration of buprenorphine (BN) gradually decreased with increase in the gum concentration. The values of the mean residence time (MRT(0-2)) increased in proportion to increasing gum concentration. The absorption of BN from rectal gels containing 0.5, 1 and 2% (w/v) gum compared with those based upon polyethylene glycol (PEG), was more rapid. In particular, the absorption of BN from rectal gels containing 1% (w/v) gum was extremely fast without decreasing the areas under the plasma concentration vs. time curves (AUC(0-2)). The bioavailabilities obtained in rabbits correlated well with the in vitro release rates determined using dialysis tubing. A histopathological study revealed severe mucosal hyperemia, which was thought to be the main characteristic of rectal irritation induced by PEG-base suppositories. These results suggested that BN-HCl rectal gels prepared with xanthan gum and locust bean gum were practical rectal preparations with rapid absorption and reduced side effects.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 26 条
  • [1] ADRIAENSEN H, 1985, ACTA ANAESTH BELG, V1, P33
  • [2] AOYAGI N, 1988, CHEM PHARM BULL, V36, P4933
  • [3] BILIARY-EXCRETION, METABOLISM AND ENTEROHEPATIC CIRCULATION OF BUPRENORPHINE
    BREWSTER, D
    HUMPHREY, MJ
    MCLEAVY, MA
    [J]. XENOBIOTICA, 1981, 11 (03) : 189 - 196
  • [4] BULLINGHAM RES, 1981, BRIT J CLIN PHARMACO, V12, P117
  • [5] CONTROLLED BUCCAL DELIVERY OF BUPRENORPHINE
    CASSIDY, JP
    LANDZERT, NM
    QUADROS, E
    [J]. JOURNAL OF CONTROLLED RELEASE, 1993, 25 (1-2) : 21 - 29
  • [6] RECTAL MUCOSA DAMAGE IN RABBITS AFTER SUBCHRONICAL APPLICATION OF SUPPOSITORY BASES
    DEMUYNCK, C
    CUVELIER, C
    VANSTEENKISTE, D
    BONNARENS, L
    REMON, JP
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (07) : 945 - 950
  • [7] THE SYSTEMIC AVAILABILITY OF BUPRENORPHINE ADMINISTERED BY NASAL SPRAY
    ERIKSEN, J
    JENSEN, NH
    KAMPJENSEN, M
    BJARNO, H
    FRIIS, P
    BREWSTER, D
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (11) : 803 - 805
  • [8] DETERMINATION OF BUPRENORPHINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION - APPLICATION TO HUMAN AND RABBIT PHARMACOKINETIC STUDIES
    HO, ST
    WANG, JJ
    HO, WB
    HU, OYP
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 570 (02): : 339 - 350
  • [9] BIOPHARMACEUTICAL CHARACTERISTICS OF A SUPPOSITORY BASE CONTAINING POLY (OXYETHYLENE)-POLY (OXYPROPYLENE) COPOLYMER, UNILUBE .1. EFFECTS OF A SUPPOSITORY BASE CONTAINING UNILUBE 70DP-950B ON RELEASE AND RECTAL ABSORPTION OF AMINOPYRINE IN RABBIT
    ITOH, S
    MORISHITA, N
    YAMAZAKI, M
    SUGINAKA, A
    TANABE, K
    SAWANOI, M
    [J]. JOURNAL OF PHARMACOBIO-DYNAMICS, 1987, 10 (04): : 173 - 179
  • [10] STUDIES ON SUSTAINED-RELEASE SUPPOSITORIES .3. RECTAL ABSORPTION OF MORPHINE IN RABBITS AND PROLONGATION OF ITS ABSORPTION BY ALGINIC ACID ADDITION
    KAWASHIMA, S
    INOUE, Y
    SHIMENO, T
    FUJIWARA, H
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1990, 38 (02) : 498 - 505